Ventyx Biosciences Inc. (VTYX) may enjoy gains as insiders got busy in the recent days


Ventyx Biosciences Inc.’s recent filing unveils that its insider Sandborn William J. unloaded Company’s shares for reported $0.4 million on Aug 31. In the deal valued at $33.64 per share,11,900 shares were sold. As a result of this transaction, Sandborn William J. now holds 48,389 shares worth roughly $ 1.63 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, Sandborn William J. sold 3,494 shares, generating $114,810 in total proceeds. Upon selling the shares at $32.86, the insider now owns 24,194 shares.

Before that, Mohan Raju sold 30,000 shares. Ventyx Biosciences Inc. shares valued at $1,005,570 were divested by the Chief Executive Officer at a price of $33.52 per share. As a result of the transaction, Mohan Raju now holds 1,512,911 shares, worth roughly $51.06 million.

PT values the company’s stock at a premium of 46.43 to its Friday closing price.

Price Performance Review of VTYX

On Friday, Ventyx Biosciences Inc. [NASDAQ:VTYX] saw its stock jump 0.75% to $33.75. On the same session, the stock had its day’s lowest price of $33.20, but rose to a high of $34.24. Over the last five days, the stock has gained 7.55%. Ventyx Biosciences Inc. shares have risen nearly 2.93% since the year began. Nevertheless, the stocks have risen 65.44% over the past one year. While a 52-week high of $47.25 was reached on 03/03/23, a 52-week low of $20.60 was recorded on 04/10/23. SMA at 50 days reached $34.22, while 200 days put it at $35.02. A total of 0.27 million shares were traded, compared to the trading of 0.37 million shares in the previous session.

Levels Of Support And Resistance For VTYX Stock

The 24-hour chart illustrates a support level at 33.22, which if violated will result in even more drops to 32.69. On the upside, there is a resistance level at 34.26. A further resistance level may holdings at 34.77. The Relative Strength Index (RSI) on the 14-day chart is 53.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.71, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 10.02%. Stochastics %K at 84.77% indicates the stock is a selling.

How much short interest is there in Ventyx Biosciences Inc.?

A steep rise in short interest was recorded in Ventyx Biosciences Inc. stocks on Aug 14, 2023, dropping by 100000.0 shares to a total of 9.32 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 9.42 million shares. There was a decline of -1.07%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 23.83% of the overall stock float, the days-to-cover ratio (short ratio) fell to 16.96.

Ventyx Biosciences Inc. [VTYX] – Who Are The Largest Shareholders?

In filings from Fidelity Management & Research Co, it is revealed that the company now owns 7,553,565 shares, or roughly 12.83% of the outstanding VTYX shares. In other words, the investor’s shares have risen by 855,828 from its previous 13-F filing of 6697737.0. Additionally, T. Rowe Price Associates, Inc. increased 45.81% of its stake after which the total value it holdings stand at $144,248,284, while BlackRock Fund Advisors added 54.49% of its stake to hold $105.15 million in the firm. Over the last quarter, Citadel Advisors LLC sold -225,701 shares of Ventyx Biosciences Inc., while Capital Research & Management Co sold 350,068 shares. At present, Lord, Abbett & Co. LLC is holding 2,317,175 shares valued at $85.85 million. The Vanguard Group, Inc. owned 2,269,628 shares of the company at the time of its most recent 13F filing, worth $84.09 million.

According to FactSet, Ventyx Biosciences Inc.’s share price will average $56.75 in the next year, based on opinions of analysts polled by the firm. This is up nearly 64.18 percent from its previous closing price of $33.50. Analysts expect Ventyx Biosciences Inc. stock to reach the higher price of $77.00, while the lowest price estimate is $46.00. However, 12 analysts have rated VTYX stock as a Buy in their predictions for 2023.


Please enter your comment!
Please enter your name here